{"id":9906,"date":"2018-08-14T09:30:33","date_gmt":"2018-08-14T13:30:33","guid":{"rendered":"https:\/\/www.consigli.com\/?p=9906"},"modified":"2020-12-09T11:05:31","modified_gmt":"2020-12-09T16:05:31","slug":"building-life-sciences-facilities-that-benefit-our-lives","status":"publish","type":"post","link":"https:\/\/www.consigli.com\/building-life-sciences-facilities-that-benefit-our-lives\/","title":{"rendered":"Building Life Sciences Facilities that Benefit Our Lives"},"content":{"rendered":"
The life sciences industry affects our lives \u2013 every day. Be it a diagnostic test, a prescription medicine, or even treatments for animals, we all benefit from advances.<\/p>\n
With the increasing demand for products from our aging population, public investment is at all-time high– $1 billion in investment is forecast over the next ten years in Massachusetts alone. This industry, which formerly had plenty of options for leasable space, is actively seeking new opportunities for growth. Consigli is working on life science projects throughout the Northeast, including new development, renovations of existing buildings and tenant fit-outs.<\/p>\n
We recently completed one such project for ImmuCell, a Maine-based animal health medicine manufacturer. We served as the construction manager to expand their Portland headquarters with a new, 16,000 SF cGMP facility for the production of a new biologic treatment of a common infection found in cows worldwide.<\/p>\n
Immucell\u2019s existing facility housed products regulated by the USDA; this new product requires more stringent FDA approval. The company decided to build a new facility for the product that would include space for fermentation, laboratory, processing and a storage warehouse.<\/p>\n
As with the development of any new product, an aggressive schedule was required to have the facility up and running so they could adhere to their planned schedule for regulatory approvals; meaning the build-out had to happen over the course of 11 months.<\/p>\n
Some of the steps taken to meet this challenging construction schedule include:<\/p>\n
Construction began before design was complete<\/strong>. The\u00a0cGMP\u00a0facility was built in two phases. The first phase was the\u00a0construction of the core and shell.\u00a0 This process began in September of 2016, and completing as much as possible before winter set in was a priority.\u00a0 The second phase\u00a0was the fit-out, which focused on installation of production equipment and support space customized to the treatment’s unique manufacturing process. The fast-track construction schedule included major bid packages,\u00a0such as high purity process piping and process control valves and automation, as well as long lead process-related equipment.<\/p>\n The opportunity to be part of the growth and the development of companies behind pioneering research, innovative solutions and lifesaving cures, allows us to contribute to progress each and every day.<\/p>\n Consigli is constantly researching ways to make the construction process more efficient; from worker productivity to technological innovation. We recently embarked on a study of the daily protocols required by our workers in clean room environments; from entering the building through gowning up and other protocols. This data shows that almost one-fifth of a worker\u2019s day can be spent on maintaining protocols; so we\u2019re finding new ways we can minimize the time it takes our workers to begin daily tasks in clean room environments while still adhering to strict guidelines\u2026thereby maximizing progress and reducing project schedules in the process.<\/p>\n","protected":false},"excerpt":{"rendered":" The life sciences industry affects our lives \u2013 every day. Be it a diagnostic test, a prescription medicine, or even treatments for animals, we all benefit from advances. With the increasing demand for products from our aging population, public investment is at all-time high– $1 billion in investment is forecast<\/p>\n","protected":false},"author":2,"featured_media":10023,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[2],"tags":[187,190,186,145,44,188,189,45],"class_list":["post-9906","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-insights","tag-cgmp","tag-clean-room","tag-immucell","tag-life-science","tag-maine","tag-maufacturing","tag-pharma","tag-portland"],"acf":[],"aioseo_notices":[],"yoast_head":"\n\n
\n